E

Energenesis Biomedical Co Ltd
TWSE:6657

Watchlist Manager
Energenesis Biomedical Co Ltd
TWSE:6657
Watchlist
Price: 41.05 TWD -4.53% Market Closed
Market Cap: 3.6B TWD

Wall Street
Price Targets

Price Targets Summary
Energenesis Biomedical Co Ltd

There are no price targets for Energenesis Biomedical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Energenesis Biomedical Co Ltd Competitors:
Price Targets
XOMA
XOMA Corp
146% Upside
ADOC
Adocia SA
131% Upside
PTGX
Protagonist Therapeutics Inc
10% Upside
SVRA
Savara Inc
74% Upside
AUPH
Aurinia Pharmaceuticals Inc
12% Upside
ADCT
ADC Therapeutics SA
131% Upside
OCC
Orthocell Ltd
21% Upside
KURA
Kura Oncology Inc
224% Upside

Revenue
Forecast

Revenue Estimate
Energenesis Biomedical Co Ltd

For the last 8 years the compound annual growth rate for Energenesis Biomedical Co Ltd's revenue is 3%. The projected CAGR for the next 2 years is 3%.

3%
Past Growth
3%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Energenesis Biomedical Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Energenesis Biomedical Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Energenesis Biomedical Co Ltd's stock price target?
Not Available

Energenesis Biomedical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Energenesis Biomedical Co Ltd's Revenue forecast?
Projected CAGR
3%

For the last 8 years the compound annual growth rate for Energenesis Biomedical Co Ltd's revenue is 3%. The projected CAGR for the next 2 years is 3%.

Back to Top